review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Linley E Watson | |
Eric J MacLaughlin | |||
David E Dostal | |||
Sandhya Sanghi | |||
Coty W Jewell | |||
Peter J Naus | |||
Sheldon Chaffer | |||
P433 | issue | 2 | |
P304 | page(s) | 85-100 | |
P577 | publication date | 2006-06-01 | |
P1433 | published in | Cardiovascular & hematological disorders drug targets | Q26867051 |
P1476 | title | Cyclooxygenase-2 inhibitors: a painful lesson | |
P478 | volume | 6 |
Q41898452 | Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. |
Q35896535 | Analgesic and anti-inflammatory effects of UP1304, a botanical composite containing standardized extracts of Curcuma longa and Morus alba |
Q43075742 | Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics. |
Q33560737 | CCK2 receptor expression transforms non-tumorigenic human NCM356 colonic epithelial cells into tumor forming cells |
Q48166277 | COX-2-dependent and independent effects of COX-2 inhibitors and NSAIDs on proatherogenic changes in human monocytes/macrophages. |
Q26779680 | Can active components of licorice, glycyrrhizin and glycyrrhetinic acid, lick rheumatoid arthritis? |
Q33829618 | Central role of the brain in stress and adaptation: links to socioeconomic status, health, and disease |
Q39326522 | Clinical safety and efficacy of NG440: a novel combination of rho iso-alpha acids from hops, rosemary, and oleanolic acid for inflammatory conditions |
Q35769055 | Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk. |
Q37754720 | Eicosanoids in inflammation and cancer: the role of COX-2. |
Q37395300 | Flavocoxid, a dual inhibitor of cyclooxygenase and 5-lipoxygenase, blunts pro-inflammatory phenotype activation in endotoxin-stimulated macrophages |
Q35898102 | Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) Downregulates the Expression of Protumor Factors Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in a GM-CSF Receptor-Independent Manner in Cervical Cancer Cells |
Q40870546 | Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo. |
Q35496280 | Intra-articular tibiofemoral injection of a nonsteroidal anti-inflammatory drug has no detrimental effects on joint mechanics in a rat model |
Q34410269 | Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions |
Q43143481 | META060 inhibits osteoclastogenesis and matrix metalloproteinases in vitro and reduces bone and cartilage degradation in a mouse model of rheumatoid arthritis |
Q33849200 | Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E2, dual specificity phosphatase 1 and tristetraprolin. |
Q39063947 | Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspective |
Q33602583 | Novel role of granulocyte-macrophage colony-stimulating factor: antitumor effects through inhibition of epithelial-to-mesenchymal transition in esophageal cancer |
Q37313738 | Nutrition and age-associated inflammation: implications for disease prevention |
Q24245985 | Oral non steroid anti-inflammatories for bronchiectasis in children and adults |
Q24242964 | Oral non steroid anti-inflammatories for children and adults with bronchiectasis |
Q58770742 | Six-month safety evaluation of robenacoxib tablets (Onsior™) in dogs after daily oral administrations |
Q40258257 | Species differential regulation of COX2 can be described by an NFκB-dependent logic AND gate |
Q36856251 | The effect of local corticosteroid or ketorolac exposure on histologic and biomechanical properties of rabbit tendon and cartilage. |
Q46885693 | The effects of COX-1 and COX-2 inhibitors on prostaglandin synthesis and the formation of heterotopic bone in a rat model |
Q43080595 | UP446, analgesic and anti-inflammatory botanical composition |